Information Sources and Attitudes Toward COVID-19 Vaccination at a Free Clinic in the State of Nebraska, USA

Journal of Community Health - Tập 48 - Trang 252-259 - 2022
Elle Nuttall1, Sarah Ives1, Anna White1, Kiara Gallagher1, Rosemary Pynes1, Ryan W. Walters2, Meera Varman3
1Creighton University School of Medicine, Criss Health Sciences Complex II, Omaha, USA
2Department of Clinical Research and Public Health, Creighton University School of Medicine, Omaha, USA
3Department of Pediatrics, Creighton University School of Medicine, Omaha, USA

Tóm tắt

The full impacts of the COVID-19 pandemic are yet to be determined. While highly effective vaccines are available to prevent and decrease the severity of COVID-19 infection, significant COVID-19 vaccine hesitancy remains. Understanding motivations, discouraging factors, opinions, and information sources regarding COVID-19 is essential to targeting vaccine hesitancy and improving vaccine uptake. A 25 question survey was administered to the patients of a free clinic in the Midwest to assess patient demographic data, opinions about and experience with COVID-19, the COVID-19 vaccines, and information sources. The main outcome of interest was if vaccination status influenced information sources and opinions regarding COVID-19. This study also analyzed motivating and discouraging factors for vaccination. The study had a total of 104 participants with 7 being excluded. There were a total of 97 survey responses included in this study, there were 79 vaccinated patients and 18 unvaccinated patients. This survey study found differences in information sources between vaccinated and unvaccinated groups. Opinions surrounding the COVID-19 vaccine, public health agencies, and perceived severity of COVID-19 also varied between vaccinated and unvaccinated groups. The differential information sources and opinions between vaccinated and unvaccinated groups emphasizes the importance of access to high-quality sources and educating the community to improve public health.

Tài liệu tham khảo

Centers for Disease Control and Prevention. (2022, June 13). CDC Covid data tracker. Centers for Disease Control and Prevention. Retrieved July 2, 2022, from https://covid.cdc.gov/covid-data-tracker/#datatracker-home Food and Drug Administration. (2022, March 29). Moderna Covid-19 vaccine fact sheet for recipients and caregivers. Retrieved June 14, 2022, from https://cacmap.fda.gov/media/144638/download Office of the Commissioner. (2021, May 10). Coronavirus (COVID-19) update: FDA authorizes Pfizer BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic. U.S. Food and Drug Administration. Retrieved June 14, 2022, from https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use Center for Biologics Evaluation and Research. (2020, November 11). Emergency use authorization for vaccines explained. U.S. Food and Drug Administration. Retrieved June 14, 2022, from https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained Office of the Commissioner. (2021, August 23). FDA approves first COVID-19 vaccine. U.S. Food and Drug Administration. Retrieved June 14, 2022, from https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine Office of the Commissioner. (2022, May 16). Spikevax and Moderna Covid-19 vaccine. U.S. Food and Drug Administration. Retrieved June 14, 2022, from https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/spikevax-and-moderna-covid-19-vaccine#:~:text=On%20January%2031%2C%202022%2C%20the,years%20of%20age%20and%20older Office of the Commissioner. (2022, May 11). Janssen Covid-19 vaccine. U.S. Food and Drug Administration. Retrieved June 14, 2022, from https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine Jarrett, C., Wilson, R., O’Leary, M., Eckersberger, E., & Larson, H. J. (2015). Strategies for addressing vaccine hesitancyA systematic review. Vaccine, 33(34), 4180–4190. https://doi.org/10.1016/j.vaccine.2015.04.040 Coe, A., Elliott, M., Gatewood, S., Goode, J., & Moczygemba, L. (2022). Perceptions and predictors of intention to receive the COVID-19 vaccine. Research in Social and Administrative Pharmacy. https://doi.org/10.1016/j.sapharm.2021.04.023 Kricorian, K., Civen, R., & Equils, O. (2022). COVID-19 vaccine hesitancy: Misinformation and perceptions of vaccine safety. Human vaccines & immunotherapeutics, 18(1), 1950504. https://doi.org/10.1080/21645515.2021.1950504 Rittle, C. (2022). Covid-19 vaccine hesitancy and how to address it. Workplace Health & Safety, 70(2), 56–62. https://doi.org/10.1177/21650799211073525 Tsai, R., Hervey, J., Hoffman, K., Wood, J., Johnson, J., Deighton, D., Clermont, D., Loew, B., & Goldberg, S. L. (2022). COVID-19 vaccine hesitancy and acceptance among individuals with cancer, autoimmune diseases, or other serious comorbid conditions: Cross-sectional, internet-based survey. JMIR public health and surveillance, 8(1), e29872. https://doi.org/10.2196/29872 Nguyen, L. H., Joshi, A. D., Drew, D. A., et al. (2022). Self-reported COVID-19 vaccine hesitancy and uptake among participants from different racial and ethnic groups in the United States and United Kingdom. Nature Communications, 13, 636. https://doi.org/10.1038/s41467-022-28200-3 Al-Uqdah, L., Franklin, F. A., Chiu, C.-C., & Boyd, B. N. (2022). Associations between social media engagement and vaccine hesitancy. Journal of Community Health, 47(4), 577–587. https://doi.org/10.1007/s10900-022-01081-9 Jennings, W., Stoker, G., Bunting, H., et al. (2021). Lack of trust, conspiracy beliefs, and social media use predict COVID-19 vaccine hesitancy. Vaccines, 9, 593. https://doi.org/10.3390/vaccines9060593 Reno, C., Maietti, E., Di Valerio, Z., Montalti, M., Fantini, M. P., & Gori, D. (2021). Vaccine hesitancy towards COVID-19 vaccination: Investigating the role of information sources through a mediation analysis. Infectious Disease Reports, 13, 712–723. https://doi.org/10.3390/idr13030066 King, W. C., Rubinstein, M., Reinhart, A., & Mejia, R. (2021). Time trends, factors associated with, and reasons for COVID-19 vaccine hesitancy: A massive online survey of US adults from January-May 2021. PLoS ONE, 16(12), e0260731. https://doi.org/10.1371/journal.pone.0260731 Padamsee, T. J., Bond, R. M., Dixon, G. N., Hovick, S. R., Na, K., Nisbet, E. C., Wegener, D. T., & Garrett, R. K. (2022). Changes in COVID-19 vaccine hesitancy among black and white individuals in the US. JAMA Network Open, 5(1), e2144470. https://doi.org/10.1001/jamanetworkopen.2021.44470 Rutjens, B. T., Sengupta, N., van der Lee, R., van Koningsbruggen, G. M., Martens, J. P., Rabelo, A., & Sutton, R. M. (2022). Science skepticism across 24 countries. Social Psychological and Personality Science, 13(1), 102–117. https://doi.org/10.1177/19485506211001329 Williams, J. T. B., Rice, J. D., & O’Leary, S. T. (2021). Associations between religion, religiosity, and parental vaccine hesitancy. Vaccine X, 9, 100121. https://doi.org/10.1016/j.jvacx.2021.100121